<bill session="116" type="s" number="1584" updated="2019-07-16T09:29:20Z">
  <state datetime="2019-05-21">REFERRED</state>
  <status>
    <introduced datetime="2019-05-21"/>
  </status>
  <introduced datetime="2019-05-21"/>
  <titles>
    <title type="official" as="introduced">A bill to hold pharmaceutical companies accountable for dubious marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic in the United States.</title>
    <title type="short" as="introduced">Opioid Crisis Accountability Act of 2019</title>
    <title type="short" as="introduced">Opioid Crisis Accountability Act of 2019</title>
    <title type="display">Opioid Crisis Accountability Act of 2019</title>
  </titles>
  <sponsor bioguide_id="S000033"/>
  <cosponsors>
    <cosponsor bioguide_id="B001267" joined="2019-05-21"/>
    <cosponsor bioguide_id="B001277" joined="2019-05-21"/>
    <cosponsor bioguide_id="H001075" joined="2019-05-21"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-21">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-05-21" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="identical" number="2917"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Child health"/>
    <term name="Civil actions and liability"/>
    <term name="Consumer affairs"/>
    <term name="Corporate finance and management"/>
    <term name="Criminal procedure and sentencing"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Government studies and investigations"/>
    <term name="Government trust funds"/>
    <term name="Health care coverage and access"/>
    <term name="Health programs administration and funding"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
    <term name="Securities"/>
    <term name="Wages and earnings"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
